![](https://www.diabetesnews.com/wp-content/uploads/2012/10/199845-pill_bottle_and_pills_large-150x150.jpg)
Eli Lilly & Co’s experimental once-weekly diabetes drug dulaglutide proved superior in late-stage clinical trials to three other widely used medicines that are dosed more frequently, the company said on Monday.
Read more
Eli Lilly & Co’s experimental once-weekly diabetes drug dulaglutide proved superior in late-stage clinical trials to three other widely used medicines that are dosed more frequently, the company said on Monday.
Read more